EE9400337A - Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused - Google Patents

Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused

Info

Publication number
EE9400337A
EE9400337A EE9400337A EE9400337A EE9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A EE 9400337 A EE9400337 A EE 9400337A
Authority
EE
Estonia
Prior art keywords
pharmaceutical compositions
compositions containing
interferon alpha
containing interferon
alpha
Prior art date
Application number
EE9400337A
Other languages
English (en)
Estonian (et)
Inventor
J. Spiegel Robert
M. Cuss Francis
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of EE9400337A publication Critical patent/EE9400337A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EE9400337A 1990-12-14 1994-11-21 Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused EE9400337A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62824090A 1990-12-14 1990-12-14

Publications (1)

Publication Number Publication Date
EE9400337A true EE9400337A (et) 1996-02-15

Family

ID=24518070

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400337A EE9400337A (et) 1990-12-14 1994-11-21 Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused

Country Status (11)

Country Link
EP (1) EP0563177A1 (fr)
JP (1) JPH06503570A (fr)
AU (1) AU9139091A (fr)
CA (1) CA2098393A1 (fr)
EE (1) EE9400337A (fr)
IE (1) IE914326A1 (fr)
IL (1) IL100332A0 (fr)
MX (1) MX9102512A (fr)
PT (1) PT99784A (fr)
WO (1) WO1992010207A1 (fr)
ZA (1) ZA919769B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
ES2161793T3 (es) * 1994-04-09 2001-12-16 Hoffmann La Roche Proceso para la produccion de alfa-interferona.
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
US6207145B1 (en) 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
CN1151840C (zh) * 1996-05-09 2004-06-02 太平洋制药控股公司 干扰素在制备用于治疗哺乳动物肿瘤病的药剂中的应用
ATE316792T1 (de) * 1996-05-09 2006-02-15 Pharma Pacific Pty Ltd Stimulierung wirtseigener abwehrmechanismen gegen krebs
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (fr) * 1981-10-13 1988-03-16 Exovir, Inc. Compositions contenant de l'interféron et application de ces compositions dans le traitement des infections herpétiques, lésions prémalignes de la peau, malignités de la peau et psoriasis
AU634511B2 (en) * 1988-12-01 1993-02-25 Schering Corporation Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
MX9102512A (es) 1992-06-01
EP0563177A1 (fr) 1993-10-06
IL100332A0 (en) 1992-09-06
ZA919769B (en) 1992-09-30
JPH06503570A (ja) 1994-04-21
PT99784A (pt) 1992-12-31
CA2098393A1 (fr) 1992-06-15
IE914326A1 (en) 1992-06-17
WO1992010207A1 (fr) 1992-06-25
AU9139091A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
BR1100824A (pt) Composto e composição farmacêutica
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
HU9802116D0 (en) 19-nor-d-vitamin compounds with biologically effect and pharmaceutical compositions containing them
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE10199066I1 (de) Pharmazeutische Zusammensetzung
BR9200058A (pt) Composto e composicao farmaceutica
ITRM910952A0 (it) Composizioni farmaceutiche contenenti gonadotropine
MX9200622A (es) Composicion farmaceutica
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
DE4294862T1 (de) Pharmazeutische Komposition
KR890016965A (ko) 항생작용을 하는 조성물 및 이들의 용도
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
UA26064A1 (uk) Фармацевтичhа композиція
IT9020144A0 (it) Composizione farmaceutica contenente egf
BR8905444A (pt) Composicoes e aplicacao
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI920845A (fi) Farmaceutiska kompositioner innehaollande interleukin-2
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
BR1100486A (pt) Composto e composição farmacêutica